Related Experiment Videos
L-carnitine may attenuate free fatty acid-induced endothelial dysfunction
Sudha S Shankar1, Bahram Mirzamohammadi, James P Walsh
1Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202-5111, USA.
Annals of the New York Academy of Sciences
|December 14, 2004
Summary
Elevated free fatty acids (FFA) impair vascular function. L-carnitine supplementation improved endothelial function in lean subjects experiencing FFA elevation, suggesting a potential therapeutic role for L-carnitine in obesity-related cardiovascular disease.
Area of Science:
- Cardiovascular Physiology
- Metabolic Health
- Endothelial Function
Background:
- Elevated free fatty acids (FFA) are linked to endothelial dysfunction in obesity and insulin resistance.
- L-carnitine plays a crucial role in fatty acid metabolism and has shown promise in improving vascular health in diabetic and cardiac patients.
Purpose of the Study:
- To investigate the hypothesis that L-carnitine can mitigate endothelial dysfunction induced by elevated free fatty acids (FFA).
Main Methods:
- Assessed leg blood flow (LBF) and leg vascular resistance (LVR) responses to methacholine chloride (MCh) infusions in normal lean subjects.
- Measurements were taken under basal conditions, during elevated FFA levels, and with L-carnitine superimposed on elevated FFA.
Main Results:
- Elevated FFA significantly reduced the maximal increase in LBF and the maximal decrease in LVR in response to MCh.
- Co-administration of L-carnitine restored LBF increments and LVR decreases to levels comparable to basal conditions, indicating attenuation of FFA-induced endothelial dysfunction.
Conclusions:
- L-carnitine supplementation appears to attenuate free fatty acid-induced endothelial dysfunction.
- Increasing L-carnitine levels may offer a strategy to improve obesity-associated endothelial dysfunction and potentially reduce cardiovascular disease risk.